Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Minocycline].

C Bernier1, B Dréno

  • 1Clinique Dermatologique, Hôtel-Dieu, Place Alexis Ricordeau, 44093 Nantes Cedex 1.

Annales De Dermatologie Et De Venereologie
|June 28, 2001
PubMed
Summary
This summary is machine-generated.

Minocycline, a second-generation tetracycline, offers anti-infective and anti-inflammatory benefits, particularly for acne and STDs. While not more potent than other tetracyclines, it acts faster and has fewer side effects like photosensitivity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and Outcomes of Direct Challenge in Adults With a History of Childhood Penicillin Allergy: A Multicenter Study.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

Prevalence and impact of solar lentigines: An international survey.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Evolution of the sentinel lymph node procedure following the approval of adjuvant anti-PD-1 therapy for stage IIB and IIC melanoma: A multicenter study from RICMEL database.

Annales de dermatologie et de venereologie·2026
Same author

Eczema following IL-5 inhibitors for the treatment of severe asthma with improvement after switching to an IL-4Rα mAb.

The journal of allergy and clinical immunology. In practice·2025
Same author

Allergological work-up of severe cutaneous adverse reactions with suspicion of anxiolytics or sleeping pills. A multicenter retrospective study of 20 cases.

Annales de dermatologie et de venereologie·2025
Same author

Edible squash poisoning: cause of hair loss and exanthema.

Annales de dermatologie et de venereologie·2025
Same journal

2024 guidelines (S3) for the therapeutic management of patients with genital herpes.

Annales de dermatologie et de venereologie·2026
Same journal

Topical JAK inhibitors in the lichen planus spectrum: a systematic review.

Annales de dermatologie et de venereologie·2026
Same journal

2024 recommendations for the therapeutic management of anogenital warts.

Annales de dermatologie et de venereologie·2026
Same journal

Successful use of thalidomide in treating metastatic Crohn's disease.

Annales de dermatologie et de venereologie·2026
Same journal

Multiple cutaneous juvenile xanthogranuloma: a monocentric study.

Annales de dermatologie et de venereologie·2026
Same journal

Cartilage-hair-hypoplasia associated with granulomatosis induced by rubella vaccine.

Annales de dermatologie et de venereologie·2026
See all related articles

Area of Science:

  • Pharmacology and Dermatology
  • Antimicrobial and Anti-inflammatory Agents
  • Tetracycline Antibiotics

Context:

  • Minocycline, a second-generation tetracycline derivative, was developed in the 1960s.
  • It exhibits broad-spectrum anti-infective properties against bacteria like Chlamydia, Treponema, and Propionibacterium acnes.
  • Its anti-inflammatory effects, particularly on epidermal cytokines, are notable.

Purpose:

  • To review the pharmacological properties, clinical efficacy, and safety profile of minocycline.
  • To assess its applications in dermatology, focusing on acne and sexually transmitted diseases (STDs).
  • To compare its effectiveness and side effect profile with other tetracyclines.

Summary:

  • Minocycline demonstrates excellent absorption, a long half-life, and good tissue distribution due to its lipophilic nature.

Related Experiment Videos

  • Clinical trials indicate efficacy in acne and STDs, with faster action than tetracycline, though not superior to first-generation tetracyclines or doxycycline.
  • It is also effective for conditions like nocardiasis, leprosy, and Lyme disease, though evidence is based on smaller, open-label studies.
  • Common side effects are less frequent than with older tetracyclines, with dizziness being a specific adverse effect. Rare severe reactions include hypersensitivity and autoimmune disorders.

    • Impact:

    • Minocycline is a valuable therapeutic option in dermatology for acne and specific STDs.
    • Its favorable pharmacokinetic profile and reduced side effects compared to older tetracyclines enhance patient compliance.
    • Further research in open-label conditions could elucidate its full therapeutic potential across various dermatological indications.